Aurobindo Pharma, a prominent pharmaceutical company, has reported a fire incident at its wholly-owned subsidiary, APL Healthcare Ltd, located in Naidupeta, Andhra Pradesh. The fire occurred in the granulation area-10 of Unit-IV, a Special Economic Zone (SEZ) unit, due to a short circuit. The blaze spread to a nearby panel, causing partial damage to granulation area-8. Fortunately, the in-house fire hydrant team, along with external fire tenders, quickly controlled the fire, and no casualties or injuries were reported.
The incident has temporarily disrupted production, with two out of 19 production lines impacted. These lines are expected to remain non-operational for approximately two weeks. As a result, the unit’s monthly production has been reduced by about three percent. However, Aurobindo Pharma has assured that it is already working on restoring and refurbishing the affected areas and expects to resume full operations within a few weeks.
The company has emphasized its commitment to ensuring employee safety, safeguarding assets, and minimizing operational disruption. Aurobindo Pharma has implemented all necessary safety measures to protect employees and secure assets, demonstrating its proactive approach to risk management and incident response. The fire incident is not expected to have a material impact on the company’s finances or operations.
Aurobindo Pharma’s swift response to the incident and its ongoing commitment to safety and operations are testaments to its dedication to maintaining operational continuity and protecting its employees and assets. The company’s ability to quickly contain the fire and minimize damage reflects its well-established safety protocols and emergency response procedures. With the affected areas being restored and refurbished, Aurobindo Pharma is expected to bounce back to full operational capacity soon, with minimal long-term impact on its production and finances.